Clinical trial
Risperidone Depot (Microspheres) vs. Risperidone Tablets - a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia
NCT00249223 is registered in ClinicalTrials.gov with Janssen Pharmaceutica N.V., Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risperidone Depot (Microspheres) vs. Risperidone Tablets - a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia
- Lead sponsor
- Janssen Pharmaceutica N.V., Belgium
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2000
- Completion date
- December 31, 2000
- Enrollment
- 641 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.